Literature DB >> 35530373

Myocarditis and COVID-19 mRNA vaccination.

Rujittika Mungmunpuntipantip1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Year:  2022        PMID: 35530373      PMCID: PMC9057931          DOI: 10.1016/j.repc.2021.08.009

Source DB:  PubMed          Journal:  Rev Port Cardiol        ISSN: 0870-2551            Impact factor:   1.651


× No keyword cloud information.
To the Editor: We would like to comment on “Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man” by Cimaglia et al. They reported an interesting case and concluded that “myocarditis may also occur after administering the vaccine against SARS-CoV-2.” Regarding pathomechanisms, Cimaglia et al. discussed the role of autoimmunity. If there is an immunopathological process, an abnormal immunoglobulin profile should be demonstrated. An abnormal immune response might be a cause but there are also other possible causes, one of which is the induction of hyperviscosity by vaccination. A relationship between hyperviscosity and acute myocarditis has been confirmed and hyperviscosity induced by vaccination might also be a cause of myocarditis.

Conflicts of interest

The authors have no conflicts of interest to declare.
  4 in total

1.  Eosinophilic Myocarditis in a Patient With Multiple Myeloma.

Authors:  Gabriela Sanchez-Petitto; Naomi Hardy; Allen Burke; Michael G McCusker; Andrew Li; Ashraf Z Badros
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2020-04-08

2.  Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.